Serving 500+ biopharmaceutical companies globally:
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
Serving 500+ biopharmaceutical companies globally:
Generated: June 22, 2017
What is the patent landscape for Pravastatin Sodium, and what generic Pravastatin Sodium alternatives are available?
Pravastatin Sodium is a drug marketed by Cipla Ltd, Mylan, Dr Reddys Labs Inc, Lupin Pharms, Pliva Hrvatska Doo, Watson Labs, Apotex Inc, Ranbaxy Labs Ltd, Zydus Pharms Usa, Teva, Aurobindo Pharma Ltd, Accord Hlthcare, Glenmark Generics, Mylan Pharms Inc, Sandoz, and Teva Pharms. and is included in seventeen NDAs.| Patents: | 0 |
| Applicants: | 16 |
| NDAs: | 17 |
| Suppliers / Packagers: see list | 47 |
| Bulk Api Vendors: see list | 74 |
| Clinical Trials: see list | 2,466 |
| Patent Applications: see list | 5,814 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see details |
| DailyMed Link: | PRAVASTATIN SODIUM at DailyMed |
| Drug Class | HMG-CoA Reductase Inhibitor |
| Mechanism of Action | Hydroxymethylglutaryl-CoA Reductase Inhibitors |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aurobindo Pharma Ltd | PRAVASTATIN SODIUM | pravastatin sodium | TABLET;ORAL | 203367-002 | Feb 2, 2017 | AB | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
Ranbaxy Labs Ltd | PRAVASTATIN SODIUM | pravastatin sodium | TABLET;ORAL | 076445-004 | Apr 23, 2007 | DISCN | No | No | ► Subscribe | ► Subscribe | |||||||||||||||||||
Glenmark Generics | PRAVASTATIN SODIUM | pravastatin sodium | TABLET;ORAL | 077987-002 | May 11, 2007 | AB | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
Sandoz | PRAVASTATIN SODIUM | pravastatin sodium | TABLET;ORAL | 076397-001 | Oct 23, 2006 | AB | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
Accord Hlthcare | PRAVASTATIN SODIUM | pravastatin sodium | TABLET;ORAL | 207068-002 | Nov 17, 2016 | AB | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Serving 500+ biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639
Follow DrugPatentWatch:
Join the 21,660 other biopharmaceutical professionals who get our Drug Patent Expiration Alerts:
